Pathologies and Treatments

Retinal vein occlusions are the second most common cause of vascular retinal disease, after proliferative diabetic retinopathy. They are defined by dilation of the retinal veins, with hemorrhages, intraretinal edema, retinal ischemia, and macular edema.

The main risk factors are the presence of cardiovascular diseases (diabetes, hypertension, hyperlipidemia, and hypercholesterolemia). In young patients without these antecedents, it is necessary to rule out an underlying coagulopathy associated with venous occlusions and ocular arterial occlusions.

Symptoms

Sudden, painless vision loss or blurring is observed, which may initially be mild but usually worsens over the following hours or days. In some cases, there is a very severe loss of vision almost immediately.

It is important to treat the condition and appropriately prevent complications such as macular edema, neovascular glaucoma, and proliferative retinopathy.

Treatments

The treatment of venous occlusions focuses on two main objectives:

  1. Identifying modifiable risk factors and the appropriate medical treatment for them, and
  2. Identifying and treating complications that threaten vision.

A comprehensive ophthalmologic examination is essential and should include the following tests: fundus photography, autofluorescence, optical coherence tomography, and wide-field fluorescein angiography.

Today, numerous pharmacological advances have radically changed the visual prognosis for these patients. In addition to treating macular edema through various strategies or their combination (injections of anti-angiogenic drugs, sustained-release corticosteroids, micropulse laser photocoagulation), it is necessary to prevent the severe consequences of more ischemic forms through extensive photocoagulation of the affected retinal areas. In some extreme cases, surgical intervention is required for both retinal complications and those related to neovascular glaucoma.

Medicina regenerativa: Endoret

Con el tratamiento de medicina regenerativa Endoret propiciamos la reparación de la superficie ocular afectada por la sequedad ocular. Se trata de un plasma rico en factores de crecimiento para el tratamiento de las lesiones de la superficie ocular elaborado a partir de la sangre del mismo paciente. Con esta formulación individualizada se consigue una tolerancia completa y una efectividad óptima. Esta opción terapéutica revolucionaria es muy eficaz en casos de defectos epiteliales persistentes o úlceras corneales. Asimismo se puede aplicar después de una cirugía refractiva corneal, una cirugía ocular o en el Síndrome de Sjögren.

Procedures

Medicina regenerativa: Endoret

Con el tratamiento de medicina regenerativa Endoret propiciamos la reparación de la superficie ocular afectada por la sequedad ocular. Se trata de un plasma rico en factores de crecimiento para el tratamiento de las lesiones de la superficie ocular elaborado a partir de la sangre del mismo paciente. Con esta formulación individualizada se consigue una tolerancia completa y una efectividad óptima. Esta opción terapéutica revolucionaria es muy eficaz en casos de defectos epiteliales persistentes o úlceras corneales. Asimismo se puede aplicar después de una cirugía refractiva corneal, una cirugía ocular o en el Síndrome de Sjögren.

Dr. Jordi Monés,

M.D. PhD

Número de Col·legiat COMB: 22.838

Director. Doctor of Medicine and Surgery. Specialist in Ophthalmology. Specialist in Retina, Macula, and Vitreous.

If you found this interesting, feel free to share it here:

Last modified: 19/08/2025
Scroll to Top
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.